Under construction – not a live service
Sign in
Taking people in CanadaPhase 3

Multiprofen-CC to Reduce Pain in Hand Arthritis

Key facts

Where
Hamilton, CanadaSee the site
Phase
Phase 3

Where in Canada

  • St. Joseph's Healthcare HamiltonHamilton, CanadaContact: Breanne Flood, MScTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
St. Joseph's Healthcare Hamilton
Trial code
NCT06966206
Record updated
4 May 2026
Original description
This clinical trial aims to find out if using 1 gram of Multiprofen-CC cream on the hands three times a day for 4 weeks can help reduce pain in adults with hand osteoarthritis, compared to a placebo (a cream with no active medicine). The research team will also look at how Multiprofen-CC affects hand function, opioid use, and how patients feel about their overall improvement. In addition, the research team will keep track of any side effects.Read full original descriptionShow less

Multiprofen-CC to Reduce Pain in Hand Arthritis (MRP-HAND): A Crossover Randomized Controlled Trial

This clinical trial aims to find out if using 1 gram of Multiprofen-CC cream on the hands three times a day for 4 weeks can help reduce pain in adults with hand osteoarthritis, compared to a placebo (a cream with no active medicine). The research team will also look at how Multiprofen-CC affects hand function, opioid use, and how patients feel about their overall improvement. In addition, the research team will keep track of any side effects.

Participants will:

* Use both Multiprofen-CC and a placebo (a cream with no active medicine) during the study, in a random order. * Be asked to apply 1 gram of cream to their hands three times a day for 2 weeks, following the manufacturer's instructions. * Attend a visit before starting the study, after 2 weeks, and after 6 weeks. * Report any symptoms they experience during the study.

Inclusion: Adults (18+); Have been diagnosed with hand osteoarthritis according to American College of Rheumatology criteria; Experience pain and/or loss of function in one or both hands that interferes with daily life; Provide informed consent.

Exclusion: Hand surgery within the past 6 months or planned within the study period; Known allergy or contraindication to any of the study drugs or their ingredients; Have open wounds/cuts and/or skin conditions on the hand area; History of impaired kidney or liver function; Use daily opioids (other than short acting codeine) for a chronic pain condition other than hand arthritis; Unable to consent; Unable or unwilling to follow study protocol; Pregnant or breastfeeding; Rheumatoid or other inflammatory arthropathy.

ClinicalTrials.gov NCT06966206